GSK announces voluntary dismissal of first Zantac trial

Aug. 16, 2022 2:23 PM ETGSK plc (GSK)By: Dulan Lokuwithana, SA News Editor2 Comments

Zantac Box and Blister Pack

DWithers/iStock Unreleased via Getty Images

  • GSK (NYSE:GSK) announced Tuesday that the plaintiff in the first scheduled U.S. Zantac trial informed the court and other parties yesterday that he would file a notice of voluntary dismissal.
  • Zantac, also known as ranitidine, was

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.